LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Neurocrine Biosciences To Repurchase Up To $500 Mln Of Its Shares 2/21/2025 8:02:50 AM
  • Neurocrine Biosciences Inc (NBIX) Announces $500 Mln Stock Buyback 2/21/2025 8:02:23 AM
  • William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY27 Rev. Estimate To 3.54 Billion From 3.83 Billion 2/7/2025 9:55:40 AM
  • William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY26 Rev. Estimate To 3.14 Billion From 3.40 Billion 2/7/2025 9:55:26 AM
  • William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY25 Rev. Estimate To 2.62 Billion From 2.77 Billion 2/7/2025 9:55:13 AM
  • William Blair Is Cutting Neurocrine Biosciences Inc (NBIX) FY27 Estimate To 11.86 From 14.28 2/7/2025 9:54:40 AM
  • William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY26 Estimate To 9.44 From 11.67 2/7/2025 9:54:26 AM
  • William Blair Is Cutting Neurocrine Biosciences Inc (NBIX) FY25 Estimate To 6.17 From 8.03 2/7/2025 9:54:14 AM
  • William Blair Reiterates Neurocrine Biosciences Inc (NBIX) At Outperform 2/7/2025 9:49:43 AM
  • Neurocrine Biosciences Q4 EPS $1.00 Vs. $1.44 Year Ago 2/6/2025 4:03:14 PM
  • Neurocrine Biosciences Launches Phase 3 Program For Osavampator In Major Depressive Disorder Treatment 1/28/2025 8:33:11 AM
  • Neurocrine Biosciences Appoints Andrew Ratz As SVP Of Drug Development, Delivery And Device 1/23/2025 4:08:26 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap